{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:53:23Z","timestamp":1792612403054,"version":"4.5.0"},"reference-count":29,"publisher":"The Journal of Rheumatology","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Systemic sclerosis (SSc) is a rare autoimmune disease. Pulmonary complications of SSc are some of the leading causes of morbidity and mortality. The objective of this study was to determine prevalence and survival estimates of SSc and SSc with interstitial lung disease (SSc-ILD) in the Canadian province of Ontario using administrative data over 10 years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Using International Classification of Diseases, 10th revision codes adapted for Canada (ICD-10-CA), adult patients diagnosed with SSc and SSc-ILD between April 1, 2008, and March 31, 2018, were identified from the National Ambulatory Care Reporting System and the Discharge Abstract Database administrative databases. SSc was identified first, and ILD was included if presence occurred after SSc diagnosis. Prevalence estimates were determined for both SSc and SSc-ILD. For survival rates, Kaplan-Meier survival curves were generated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>At the start of the 2017\/18 fiscal year (final year of the cohort), there were 2114 prevalent SSc cases for a cumulative prevalence of 19.1 per 100,000 persons, as well as 257 prevalent cases of SSc-ILD that generated a prevalence of 2.3 cases per 100,000 persons. Mean ages were 57 and 58 years with 84% and 80% females for patients with SSc and SSc-ILD, respectively. One-, 5-, and 10-year survival rates were 85.0%, 64.5%, and 44.9% for the SSc group and 77.1%, 44.4%, and 22.0% for the SSc-ILD group, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>To our knowledge, this study provides the first population-based estimates of SSc and SSc-ILD in Canada for prevalence and survival. Results confirm that the prevalence estimates of SSc-ILD fall within the Canadian threshold for rare disease. It also demonstrates the poor survival in SSc, especially when ILD is also present.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.201049","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T12:21:01Z","timestamp":1617279661000},"page":"1427-1434","source":"Crossref","is-referenced-by-count":19,"title":["Systemic Sclerosis and Associated Interstitial Lung Disease in Ontario, Canada: An Examination of Prevalence and Survival Over 10 Years"],"prefix":"10.3899","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1479-5302","authenticated-orcid":false,"given":"Janet E.","family":"Pope","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8298-4810","authenticated-orcid":false,"given":"Kobina","family":"Quansah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3040-9988","authenticated-orcid":false,"given":"Shazia","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9584-7938","authenticated-orcid":false,"given":"Soo Jin","family":"Seung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6365-7526","authenticated-orcid":false,"given":"Jason","family":"Flavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3837-1467","authenticated-orcid":false,"given":"Martin","family":"Kolb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"key":"2022062114102628000_48.9.1427.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2009.11.003"},{"key":"2022062114102628000_48.9.1427.2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209909"},{"key":"2022062114102628000_48.9.1427.3","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes076"},{"key":"2022062114102628000_48.9.1427.4","first-page":"878","article-title":"Prevalence of systemic sclerosis in Valtrompia in northern Italy. A collaborative study of rheumatologists and general practitioners","volume":"25","author":"Air\u00f2","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"2022062114102628000_48.9.1427.5","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.111106"},{"key":"2022062114102628000_48.9.1427.6","first-page":"1867","article-title":"Increased prevalence of scleroderma in Southwestern Ontario: a cluster analysis","volume":"29","author":"Thompson","year":"2002","journal-title":"J Rheumatol"},{"key":"2022062114102628000_48.9.1427.7","doi-asserted-by":"publisher","DOI":"10.1002\/art.11073"},{"key":"2022062114102628000_48.9.1427.8","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s10067-013-2289-0","article-title":"Mortality in systemic sclerosis-a single centre study from the UK","volume":"32","author":"Strickland","year":"2013","journal-title":"Clin Rheumatol"},{"key":"2022062114102628000_48.9.1427.9","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1378\/chest.12-2768","article-title":"Influence of interstitial lung disease on outcome in systemic sclerosis: a population-based historical cohort study","volume":"144","author":"Bauer","year":"2013","journal-title":"Chest"},{"key":"2022062114102628000_48.9.1427.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2014.12.005"},{"key":"2022062114102628000_48.9.1427.11","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/art.38702","article-title":"Interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis: how similar and distinct?","volume":"66","author":"Herzog","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2022062114102628000_48.9.1427.12","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.091710"},{"key":"2022062114102628000_48.9.1427.13","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1136\/annrheumdis-2015-eular.1996","article-title":"A comparative study of the difference in clinical manifestations and disease outcomes between South Asian and Caucasian patients with systemic sclerosis in a large NHS trust, within the United Kingdom [abstract]","volume":"74","author":"Mulla","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2022062114102628000_48.9.1427.14","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21583"},{"key":"2022062114102628000_48.9.1427.15","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.121380"},{"key":"2022062114102628000_48.9.1427.16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2147\/CLEP.S191418","article-title":"Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease","volume":"11","author":"Bergamasco","year":"2019","journal-title":"Clin Epidemiol"},{"key":"2022062114102628000_48.9.1427.17","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1378\/chest.15-0003","article-title":"Predicting mortality in systemic sclerosis-associated interstitial lung disease using risk prediction models derived from idiopathic pulmonary fibrosis","volume":"148","author":"Ryerson","year":"2015","journal-title":"Chest"},{"key":"2022062114102628000_48.9.1427.18","unstructured":"Statistics Canada . Population estimates on July 1st, by age and sex\u2014Ontario. [Internet. Accessed May 12, 2021]. Available from: www150.statcan.gc.ca\/t1\/tbl1\/en\/tv.action?pid=1710000501&pickMembers%5B0%5D=1.7&pickMembers%5B1%5D=2.1"},{"key":"2022062114102628000_48.9.1427.19","unstructured":"Juurlink D , Preyra C , Croxford R , Chong A , Austin P , Tu J , Canadian Institute for Health Information Discharge Abstract Database: a validation study. ICES investigative report 2006. Toronto: Institute for Clinical Evaluative Sciences; 2006."},{"key":"2022062114102628000_48.9.1427.20","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.2147\/CLEP.S260733","article-title":"Assessment of the accuracy of using ICD-10 codes to identify systemic sclerosis","volume":"12","author":"De Almeida Chaves","year":"2020","journal-title":"Clin Epidemiol"},{"key":"2022062114102628000_48.9.1427.21","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201404-145OC"},{"key":"2022062114102628000_48.9.1427.22","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/pds.2338","article-title":"A systematic review of validated methods for identifying pulmonary fibrosis and interstitial lung disease using administrative and claims data","volume":"21","author":"Jones","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2022062114102628000_48.9.1427.23","unstructured":"Institute of Clinical Evaluative Sciences . Evidence Guiding Healthcare. [Internet. Accessed May 12, 2021]. Available from: www.ipc.on.ca\/wp-content\/uploads\/2017\/07\/2011-pe-ices-rpt.pdf"},{"key":"2022062114102628000_48.9.1427.24","doi-asserted-by":"publisher","DOI":"10.1002\/art.24339"},{"key":"2022062114102628000_48.9.1427.25","first-page":"1151","article-title":"Scleroderma prevalence in Alberta: a population-based assessment [abstract]","volume":"38","author":"Barnabe","year":"2011","journal-title":"J Rheumatol"},{"key":"2022062114102628000_48.9.1427.26","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140006"},{"key":"2022062114102628000_48.9.1427.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2014.05.010"},{"key":"2022062114102628000_48.9.1427.28","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100675"},{"key":"2022062114102628000_48.9.1427.29","unstructured":"Canadian Cancer Society . Canadian Cancer Statistics 2019. [Internet. Accessed May 12, 2021]. Available from: cancer.ca\/Canadian-Cancer-Statistics-2019-EN"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.201049","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T21:18:10Z","timestamp":1655846290000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.201049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":29,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9,1]]},"published-print":{"date-parts":[[2021,9]]}},"alternative-id":["10.3899\/jrheum.201049"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.201049","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]}}}